By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Hegenheimermattweg 125

Allschwil    CH-4123  Switzerland
Phone: 41-61-567-1600 Fax: 41-61-567-1601



Drug Discovery

Company News
Roche (RHHBY) to Pay Polyphor Up to $548 Million for Superbug Antibiotic 11/4/2013 7:13:44 AM
Polyphor Achieves First Milestone in Macrocycle Drug Discovery Collaboration With Boehringer Ingelheim Corporation 7/31/2013 9:15:00 AM
Polyphor Attracts Senior Pharma Professionals to Strengthen Its Board of Directors 6/11/2013 8:51:41 AM
Polyphor Reports Successful Phase I Results for Its Pseudomonas Selective Antibiotic POL7080 3/4/2013 11:46:40 AM
Polyphor Signs MacroFinder® Collaboration With Boehringer Ingelheim Corporation 6/12/2012 7:47:36 AM
Axxam srl and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU 7/27/2011 9:32:12 AM
Polyphor Announces First PEMfinder(R) collaboration with Big Pharma, Novartis Pharmaceuticals Corporation (NVS) 5/6/2010 10:52:14 AM
Polyphor And University of Zurich Discovers A New Class Of Antibiotics With A Novel Mode Of Action 2/23/2010 11:21:17 AM
Polyphor Discovers a New Class of Antibiotics with a Novel Mode of Action 2/19/2010 9:56:16 AM
Polyphor to Enter into an Exclusive Agreement with Allergan Inc. (AGN) for the Development of Protein Epitope Mimetics (PEM) Inhibitors for Ophthalmology; Allergan Entitled to Receive up to $61.0 Million 10/31/2008 6:27:13 AM